Search

FDA has cleared Adaptive Phage Therapeutics to start formally investigating use of its PhageBank™ to treat prosthetic joint infections. This gives APT the green light to start a phase 1/2 clinical trial in the first half of 2021 in collabor

Ruby Lin (Westmead Institute for Medical Research) and colleagues published a new paper in Current Opinion in Biotechnology detailing their vision for a nationally-networked approach to personalized phage therapy in Australia, based around

Christine Thompson, a US pharmacy student keen to learn more about bringing phage therapy into the field of pharmacy, published an interview for IDStewardship.com with Phage Directory's co-founder, Jessica Sacher. They discussed recent phag

Tom Ireland, a freelance science journalist, has published a great article in BBC Science Focus called The best way to kill a superbug? Weaponise a virus. Throughout this article, Tom introduces phages, their history, and the importance of

Armata Pharmaceuticals announced a $20 Million investment to support advancement of its clinical phage development programs. Armata aims to complete a phage clinical trial (Phase 1b/2a, P. aeruginosa) and initiate three more in 2021-2022.

BBC Future has published a great in-depth feature called 'The viruses that prey on human diseases', featuring interviews with directors of the Eliava Institute (Mzia Kutateladze) and Queen Astrid Military Hospital phage therapy unit (Jean-P

Mayo Clinic is hosting a webinar on machine learning in phage therapy Jan 27 1PM MST. Register here. Featured Speaker: Cedric Lood, Researcher-Arenberg Doctoral Program at KU Leuven University-Belgium. Gina Suh, M.D. and William Faubion, M.

Vysnova (Silver Spring, MD) is seeking a highly qualified and motivated Research Technician III - Bacteriophage Therapeutics to work on a WRAIR contract.

The TAILOR team at Baylor College of Medicine now has a YouTube channel! Check out their recent one, a recorded talk on AMR and phage therapy by one of TAILOR's founders, Dr. Anthony Maresso, called Chasing Change: A moving pandemic, an ada

US biotech company Felix Biotechnology announced the initiation of its first clinical trial, CYPHY, a phase 1/2 single center trial that will test its first targeted phage therapy candidate, YPT-01, against chronic P. aeruginosa infections

Pherecydes Pharma intends to list on the Euronext Growth® Market in Paris, a European equity trading market designed for small to medium-sized firms. Pherecydes Pharma has developed a portfolio of phages against Staphylococcus aureus, Pseud

David Lebeaux (Université de Paris) and colleagues published the first demonstration of phage therapy in a lung-transplanted cystic fibrosis patient infected with pandrug resistant A. xylosoxidans. They successfully carried out two rounds o

In the lead up to the virtual Global Phage Futures Congress February 24-26 (register here), Dr Shawna McCallin, Clinical Coordinator, Balgirst University Hospital will provide a free webinar Jan 19 at 12:00 PM Eastern on establishing a data

Check out the agenda for the 3rd Bacteriophage Therapy Summit - led by 25+ expert speakers from industry, academia and governmental bodies, this meeting will equip you with all the tools you need in order to accelerate the discovery and tra

Great in-depth narrative article in The New Yorker magazine by Nicola Twilley, which details accounts of phage therapy patients treated recently in the US, as well as the behind-the-scenes work by scientists and doctors that goes into isola

We are urgently seeking Propionibacterium avidum phages for a patient in Germany. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving th

We are urgently seeking Propionibacterium avidum phages for a patient in Germany. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By receiving th

UC San Diego has detailed the journey to recovery of another patient who has benefitted from the use of phage therapy. The case involved Maria Madrigal, a polycystic kidney disease (and kidney transplant) patient who suffered from recurrent

Diana Pires (University of Minho) and colleagues published a review article describing the present-day challenges and opportunities in phage therapy, by analyzing the outcomes of trials and case reports done to date. Along with the current

This week included Giving Tuesday, and some of you likely donated to Phages for Global Health (PGH). A message from the PGH team: "Thank you so much for your gifts yesterday — between your contributions and matching funds we raised over $18